Works matching IS 11707690 AND DT 2002 AND VI 20
Results: 125
National Institute for Clinical Excellence (NICE): Is Economic Appraisal Working?
- Published in:
- PharmacoEconomics, 2002, v. 20, n. 15, p. 95, doi. 10.2165/00019053-200220003-00010
- By:
- Publication type:
- Article
Concluding Remarks.
- Published in:
- PharmacoEconomics, 2002, v. 20, n. 15, p. 107, doi. 10.2165/00019053-200220003-00011
- By:
- Publication type:
- Article
The Value of Improving the Productivity of the Drug Development Process: Faster Times and Better Decisions.
- Published in:
- PharmacoEconomics, 2002, v. 20, n. 15, p. 1, doi. 10.2165/00019053-200220003-00001
- By:
- Publication type:
- Article
Returns on Research and Development for 1990s New Drug Introductions.
- Published in:
- PharmacoEconomics, 2002, v. 20, n. 15, p. 11, doi. 10.2165/00019053-200220003-00002
- By:
- Publication type:
- Article
A Profile of the Health Sector in the United States.
- Published in:
- PharmacoEconomics, 2002, v. 20, n. 15, p. 31, doi. 10.2165/00019053-200220003-00003
- By:
- Publication type:
- Article
Meeting the Challenges to European Healthcare: Lessons Learned from the ‘Stockholm Revolution’.
- Published in:
- PharmacoEconomics, 2002, v. 20, n. 15, p. 47, doi. 10.2165/00019053-200220003-00004
- By:
- Publication type:
- Article
The Prospects for Reform of the Japanese Healthcare System.
- Published in:
- PharmacoEconomics, 2002, v. 20, n. 15, p. 55, doi. 10.2165/00019053-200220003-00005
- By:
- Publication type:
- Article
Balancing the Cost and Value of Medications: The Dilemma Facing Clinicians.
- Published in:
- PharmacoEconomics, 2002, v. 20, n. 15, p. 67, doi. 10.2165/00019053-200220003-00006
- By:
- Publication type:
- Article
The Ågrenska Centre: A Socioeconomic Case Study of Rare Diseases.
- Published in:
- PharmacoEconomics, 2002, v. 20, n. 15, p. 73
- By:
- Publication type:
- Article
The Role of Marketing in Pharmaceutical Research and Development.
- Published in:
- PharmacoEconomics, 2002, v. 20, n. 15, p. 77, doi. 10.2165/00019053-200220003-00008
- By:
- Publication type:
- Article
Reimbursement and Cost Containment: A German Perspective.
- Published in:
- PharmacoEconomics, 2002, v. 20, n. 15, p. 87, doi. 10.2165/00019053-200220003-00009
- By:
- Publication type:
- Article
Health state preference assessment in diabetic peripheral neuropathy.
- Published in:
- 2002
- By:
- Publication type:
- journal article
Use of randomised controlled trials for producing cost-effectiveness evidence: potential impact of design choices on sample size and study duration.
- Published in:
- 2002
- By:
- Publication type:
- journal article
Quality of life in patients with epilepsy and impact of treatments.
- Published in:
- 2002
- By:
- Publication type:
- journal article
Developing the revised NICE appraisal technical guidance to manufacturers and sponsors: opportunity or threat?
- Published in:
- 2002
- By:
- Publication type:
- journal article
Theoretical arguments for the discounting of health consequences: where do we go from here?
- Published in:
- 2002
- By:
- Publication type:
- journal article
Pharmacoeconomic considerations in assessing and selecting congestive heart failure therapies.
- Published in:
- 2002
- By:
- Publication type:
- journal article
Cost-effectiveness analysis of enoxaparin versus unfractionated heparin in the secondary prevention of acute coronary syndrome.
- Published in:
- 2002
- By:
- Publication type:
- journal article
Insulin lispro: a pharmacoeconomic review of its use in diabetes mellitus.
- Published in:
- 2002
- By:
- Publication type:
- journal article
The economic costs of early stage prostate cancer.
- Published in:
- 2002
- By:
- Publication type:
- journal article
The cost to the United Kingdom National Health Service of managing erectile dysfunction: the impact of sildenafil and prescribing restrictions.
- Published in:
- 2002
- By:
- Publication type:
- journal article
Cost-effectiveness comparison of tizanidine and baclofen in the management of spasticity.
- Published in:
- 2002
- By:
- Publication type:
- journal article
Cost-effectiveness comparison of salmeterol/fluticasone propionate versus montelukast in the treatment of adults with persistent asthma.
- Published in:
- 2002
- By:
- Publication type:
- journal article
Galantamine: a pharmacoeconomic review of its use in Alzheimer's disease.
- Published in:
- 2002
- By:
- Publication type:
- journal article
Vision-Specific Instruments for the Assessment of Health-Related Quality of Life and Visual Functioning: A Literature Review.
- Published in:
- PharmacoEconomics, 2002, v. 20, n. 12, p. 791, doi. 10.2165/00019053-200220120-00001
- By:
- Publication type:
- Article
Long term cost-of-illness in stroke: an international review.
- Published in:
- 2002
- By:
- Publication type:
- journal article
The annual societal cost of alcohol misuse in Scotland.
- Published in:
- 2002
- By:
- Publication type:
- journal article
UK department of health guidance on prescribing for impotence following the introduction of sildenafil: potential to contain costs in the average health authority district.
- Published in:
- 2002
- By:
- Publication type:
- journal article
Costs and effectiveness of using coumarins before, during and after coronary angioplasty.
- Published in:
- 2002
- By:
- Publication type:
- journal article
Combining a budgetary-impact analysis and a cost-effectiveness analysis using decision-analytic modelling techniques.
- Published in:
- 2002
- By:
- Publication type:
- journal article
Prospective Study Designs in Outcomes Research: The Case of Migraine.
- Published in:
- PharmacoEconomics, 2002, v. 20, n. 11, p. 715, doi. 10.2165/00019053-200220110-00001
- By:
- Publication type:
- Article
Cost effectiveness of implantable cardioverter defibrillator therapy versus drug therapy for patients at high risk of sudden cardiac death.
- Published in:
- 2002
- By:
- Publication type:
- journal article
Valuation of symptomatic hepatitis a in adults: estimates based on time trade-off and willingness-to-pay measurement.
- Published in:
- 2002
- By:
- Publication type:
- journal article
Economic analysis of filgrastim use for patients with acute myeloid leukaemia in the UK: a comparison of collection methods of resource use data.
- Published in:
- 2002
- By:
- Publication type:
- journal article
Cost-utility analysis of primary prophylaxis versus treatment on-demand for individuals with severe haemophilia.
- Published in:
- 2002
- By:
- Publication type:
- journal article
Conjoint analysis of a new Chemotherapy: willingness to pay and preference for the features of raltitrexed versus standard therapy in advanced Colorectal Cancer.
- Published in:
- 2002
- By:
- Publication type:
- journal article
The impact of health economics on healthcare delivery: a health economist's perspective: a primary care response.
- Published in:
- 2002
- By:
- Publication type:
- commentary
Cost effectiveness of asthma management strategies.
- Published in:
- 2002
- By:
- Publication type:
- commentary
Burden of illness in irritable bowel syndrome comparing Rome I and Rome II criteria.
- Published in:
- 2002
- By:
- Publication type:
- journal article
Cost of illness of Crohn's disease.
- Published in:
- 2002
- By:
- Publication type:
- journal article
Mycophenolate mofetil: a pharmacoeconomic review of its use in solid organ transplantation.
- Published in:
- 2002
- By:
- Publication type:
- journal article
The cost effectiveness of chlorofluorocarbon-free beclomethasone dipropionate in the treatment of chronic asthma: a cost model based on a 1-year pragmatic, randomised clinical study.
- Published in:
- 2002
- By:
- Publication type:
- journal article
Why Has the Use of Health Economic Evaluation in Japan Lagged Behind that in Other Developed Countries?
- Published in:
- PharmacoEconomics, 2002, v. 20, n. 10, p. 1, doi. 10.2165/00019053-200220002-00001
- By:
- Publication type:
- Article
Information Barriers to the Implementation of Economic Evaluations in Japan.
- Published in:
- PharmacoEconomics, 2002, v. 20, n. 10, p. 9, doi. 10.2165/00019053-200220002-00002
- By:
- Publication type:
- Article
The Development and Use of Quality-of-Life Measures to Evaluate Health Outcomes in Japan.
- Published in:
- PharmacoEconomics, 2002, v. 20, n. 10, p. 17, doi. 10.2165/00019053-200220002-00003
- By:
- Publication type:
- Article
Agenda for the Future.
- Published in:
- PharmacoEconomics, 2002, v. 20, n. 10, p. 25, doi. 10.2165/00019053-200220002-00004
- By:
- Publication type:
- Article
Cost of Illness of Crohn's Disease.
- Published in:
- PharmacoEconomics, 2002, v. 20, p. 639, doi. 10.2165/00019053-200220100-00001
- By:
- Publication type:
- Article
The Cost Effectiveness of Chlorofluorocarbon-Free Beclomethasone Dipropionate in the Treatment of Chronic Asthma: A Cost Model Based on a 1-Year Pragmatic, Randomised Clinical Study.
- Published in:
- PharmacoEconomics, 2002, v. 20, p. 653, doi. 10.2165/00019053-200220100-00002
- By:
- Publication type:
- Article
Economic Analysis of Filgrastim Use for Patients with Acute Myeloid Leukaemia in the UK: A Comparison of Collection Methods of Resource Use Data.
- Published in:
- PharmacoEconomics, 2002, v. 20, p. 665, doi. 10.2165/00019053-200220100-00003
- By:
- Publication type:
- Article
Mycophenolate Mofetil: A Pharmacoeconomic Review of its Use in Solid Organ Transplantation.
- Published in:
- PharmacoEconomics, 2002, v. 20, p. 675
- By:
- Publication type:
- Article